Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Operating Leases: 2023-2025

Historic Operating Leases for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $3.3 million.

  • CG Oncology's Operating Leases rose 4588.73% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 4588.73%. This contributed to the annual value of $52,000 for FY2024, which is 78.69% down from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Operating Leases is $3.3 million, which was up 371.53% from $706,000 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Operating Leases registered a high of $3.3 million during Q3 2025, and its lowest value of $52,000 during Q4 2024.
  • Over the past 3 years, CG Oncology's median Operating Leases value was $214,000 (recorded in 2023), while the average stood at $685,625.
  • Per our database at Business Quant, CG Oncology's Operating Leases crashed by 78.69% in 2024 and then skyrocketed by 4,588.73% in 2025.
  • CG Oncology's Operating Leases (Quarterly) stood at $244,000 in 2023, then crashed by 78.69% to $52,000 in 2024, then skyrocketed by 4,588.73% to $3.3 million in 2025.
  • Its Operating Leases stands at $3.3 million for Q3 2025, versus $706,000 for Q2 2025 and $781,000 for Q1 2025.